LENZ Therapeutics, Inc. (LENZ) Q2 2024 Earnings
LENZ·Reported August 14, 2024·After market close
Diluted EPS came in at $-0.40, beat the $-0.49 consensus by $0.09.
Diluted EPS
$-0.40beat by $0.09
Consensus: $-0.49
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about LENZ Therapeutics, Inc.'s Q2 2024 earnings report.
LENZ Therapeutics, Inc. (LENZ) reported Q2 2024 earnings on August 14, 2024 after market close.
LENZ Therapeutics, Inc. reported diluted EPS of $-0.40 for Q2 2024.
EPS beat the consensus estimate of $-0.49 by $0.09.
You can read the 10-Q periodic report (0001815776-24-000060) directly on SEC EDGAR. The filing index links above go to sec.gov.